Duration of attenuated positive and negative symptoms in individuals at clinical high risk: Associations with risk of conversion to psychosis and functional outcome

Journal of Psychiatric Research

Volumn 81, Issue , 2016, Pages 95-101

  Carrión, Ricardo E ^a,b,c   Demmin, Docia ^a   Auther, Andrea M ^a,c   McLaughlin, Danielle ^a   Olsen, Ruth ^a   Lencz, Todd ^a,b,c   Correll, Christoph U ^a,b,c   Cornblatt, Barbara A ^a,b,c  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

^b Northwell Health   (United States)

^c DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

Author keywords

Attenuated positive symptoms; Clinical high risk; Early intervention; Functional outcome; Negative symptoms; Psychosis

Indexed keywords

ADOLESCENT; ARTICLE; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GLOBAL ASSESSMENT OF FUNCTIONING; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE ASSESSMENT; NEGATIVE SYNDROME; POSITIVE SYNDROME; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOSIS; RISK ASSESSMENT; SCALE OF PRODROMAL SYMPTOM; SOCIAL INTERACTION; DISEASE COURSE; PRODROMAL SYMPTOM; PROPORTIONAL HAZARDS MODEL; PSYCHOTIC DISORDERS; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; PRODROMAL SYMPTOMS; PROPORTIONAL HAZARDS MODELS; PSYCHOTIC DISORDERS; RISK FACTORS; YOUNG ADULT;

EID: 84978919487     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2016.06.021     Document Type: Article

References (54)

1. Andreasen, N.C., Negative symptoms in schizophrenia. Definition and reliability. Archives General Psychiatry 39 (1982), 784–788.
2. Boonstra, N., Klaassen, R., Sytema, S., Marshall, M., De Haan, L., Wunderink, L., Wiersma, D., Duration of untreated psychosis and negative symptoms–a systematic review and meta-analysis of individual patient data. Schizophrenia Res. 142 (2012), 12–19.
3. Bottlender, R., Sato, T., Jager, M., Kunze, I., Groll, C., Borski, I., Moller, H.J., Does considering duration of negative symptoms increase their specificity for schizophrenia?. Schizophrenia Res. 60 (2003), 321–322.
4. Buchanan, R.W., Persistent negative symptoms in schizophrenia: an overview. Schizophr. Bull. 33 (2007), 1013–1022.
5. Cannon, T.D., Cadenhead, K., Cornblatt, B., Woods, S.W., Addington, J., Walker, E., Seidman, L.J., Perkins, D., Tsuang, M., McGlashan, T., Heinssen, R., Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch. Gen. Psychiatry 65 (2008), 28–37.
6. Carrión, R.E., Goldberg, T.E., McLaughlin, D., Auther, A.M., Correll, C.U., Cornblatt, B.A., Impact of neurocognition on social and role functioning in individuals at clinical high risk for psychosis. Am. J. Psychiatry 168 (2011), 806–813.
7. Carrión, R.E., McLaughlin, D., Goldberg, T.E., Auther, A.M., Olsen, R.H., Olvet, D.M., Correll, C.U., Cornblatt, B.A., Prediction of functional outcome in individuals at clinical high risk for psychosis. JAMA Psychiatry 70 (2013), 1133–1142.
8. Choi, J.S., Chon, M.W., Kang, D.H., Jung, M.H., Kwon, J.S., Gender difference in the prodromal symptoms of first-episode schizophrenia. J. Korean Med. Sci. 24 (2009), 1083–1088.
9. Chung, Y.C., Jung, H.Y., Kim, S.W., Lee, S.H., Shin, S.E., Shin, Y.M., Park, J.I., An, S.K., Kim, Y.H., What factors are related to delayed treatment in individuals at high risk for psychosis?. Early Interv. Psychiatry 4 (2010), 124–131.
10. Ciompi, L., Catamnestic long-term study on the course of life and aging of schizophrenics. Schizophr. Bull. 6 (1980), 606–618.
11. Cornblatt, B.A., Auther, A.M., Niendam, T., Smith, C.W., Zinberg, J., Bearden, C.E., Cannon, T.D., Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia. Schizophr. Bull. 33 (2007), 688–702.
12. Cornblatt, B.A., Carrión, R.E., Addington, J., Seidman, L., Walker, E.F., Cannon, T.D., Cadenhead, K.S., McGlashan, T.H., Perkins, D.O., Tsuang, M.T., Woods, S.W., Heinssen, R., Lencz, T., Risk factors for psychosis: impaired social and role functioning. Schizophr. Bull. 38 (2012), 1247–1257.
13. Cornblatt, B.A., Carrión, R.E., Auther, A.M., McLaughlin, D., Olsen, R.H., John, M., Correll, C.U., Psychosis prevention: a modified strategy for selecting individuals at clinical high-risk for psychosis. Am. J. Psychiatry 172 (2015), 986–994.
14. Cornblatt, B.A., Lencz, T., Smith, C.W., Correll, C.U., Auther, A.M., Nakayama, E., The schizophrenia prodrome revisited: a neurodevelopmental perspective. Schizophr. Bull. 29 (2003), 633–651.
15. Correll, C.U., Hauser, M., Auther, A.M., Cornblatt, B.A., Research in people with psychosis risk syndrome: a review of the current evidence and future directions. J. Child. Psychol. Psychiatry 51 (2010), 390–431.
16. Cuesta, M.J., García de Jalón, E., Campos, M.S., Ibáñez, B., Sánchez-Torres, A.M., Peralta, V., Duration of untreated negative and positive symptoms of psychosis and cognitive impairment in first episode psychosis. Schizophr. Res. 141 (2012), 222–227.
17. Fusar-Poli, P., Borgwardt, S., Bechdolf, A., Addington, J., Riecher-Rossler, A., Schultze-Lutter, F., Keshavan, M., Wood, S., Ruhrmann, S., Seidman, L.J., Valmaggia, L., Cannon, T., Velthorst, E., De Haan, L., Cornblatt, B., Bonoldi, I., Birchwood, M., McGlashan, T., Carpenter, W., McGorry, P., Klosterkotter, J., McGuire, P., Yung, A., The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry 70 (2013), 107–120.
18. Fusar-Poli, P., Meneghelli, A., Valmaggia, L., Allen, P., Galvan, F., McGuire, P., Cocchi, A., Duration of untreated prodromal symptoms and 12-month functional outcome of individuals at risk of psychosis. Br. J. Psychiatry 194 (2009), 181–182.
19. Haas, G.L., Sweeney, J.A., Premorbid and onset features of first-episode schizophrenia. Schizophr. Bull. 18 (1992), 373–386.
20. Häfner, H., Onset and early course as determinants of the further course of schizophrenia. Acta Psychiatr. Scand. Suppl. 102 (2000), 44–48.
21. Häfner, H., Löffler, W., Maurer, K., Hambrecht, M., an der Heiden, W., Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatr. Scand. 100 (1999), 105–118.
22. Häfner, H., Maurer, K., an der Heiden, W., ABC Schizophrenia study: an overview of results since 1996. Soc. Psychiatry Psychiatr. Epidemiol. 48 (2013), 1021–1031.
23. Häfner, H., Maurer, K., Löffler, W., an der Heiden, W., Hambrecht, M., Schultze-Lutter, F., Modeling the early course of schizophrenia. Schizophr. Bull. 29 (2003), 325–340.
24. Iyer, S.N., Boekestyn, L., Cassidy, C.M., King, S., Joober, R., Malla, A.K., Signs and symptoms in the pre-psychotic phase: description and implications for diagnostic trajectories. Psychol. Med. 38 (2008), 1147–1156.
25. Kaplan, E.L., Meier, P., Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53 (1958), 457–481.
26. Keshavan, M.S., Haas, G., Miewald, J., Montrose, D.M., Reddy, R., Schooler, N.R., Sweeney, J.A., Prolonged untreated illness duration from prodromal onset predicts outcome in first episode psychoses. Schizophr. Bull. 29 (2003), 757–769.
27. Leifker, F.R., Bowie, C.R., Harvey, P.D., Determinants of everyday outcomes in schizophrenia: the influences of cognitive impairment, functional capacity, and symptoms. Schizophr. Res. 115 (2009), 82–87.
28. Lencz, T., Smith, C.W., Auther, A., Correll, C.U., Cornblatt, B., Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia. Schizophrenia Res. 68 (2004), 37–48.
29. McGlashan, T., Walsh, B., Woods, S., The Psychosis-Risk Syndrome: Handbook for Diagnosis and Follow-Up. 2010, Oxford University Press.
30. McGlashan, T.H., Early detection and intervention of schizophrenia: rationale and research. Br. J. Psychiatry Suppl. 172 (1998), 3–6.
31. McGlashan, T.H., Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course?. Biol. Psychiatry 46 (1999), 899–907.
32. McGlashan, T.H., Johannessen, J.O., Early detection and intervention with schizophrenia: rationale. Schizophr. Bull. 22 (1996), 201–222.
33. McGorry, P.D., Killackey, E., Yung, A.R., Early intervention in psychotic disorders: detection and treatment of the first episode and the critical early stages. Med. J. Aust. 187 (2007), S8–S10.
34. Miller, T.J., McGlashan, T.H., Rosen, J.L., Cadenhead, K., Cannon, T., Ventura, J., McFarlane, W., Perkins, D.O., Pearlson, G.D., Woods, S.W., Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr. Bull. 29 (2003), 703–715.
35. Miller, T.J., McGlashan, T.H., Rosen, J.L., Somjee, L., Markovich, P.J., Stein, K., Woods, S.W., Prospective diagnosis of the initial prodrome for schizophrenia based on the structured interview for prodromal syndromes: preliminary evidence of interrater reliability and predictive validity. Am. J. Psychiatry 159 (2002), 863–865.
36. Miller, T.J., McGlashan, T.H., Woods, S.W., Stein, K., Driesen, N., Corcoran, C.M., Hoffman, R., Davidson, L., Symptom assessment in schizophrenic prodromal states. Psychiatr. Q. 70 (1999), 273–287.
37. Murphy, B.P., Stuart, A.H., McGorry, P.D., Duration of untreated negative symptoms and duration of active negative symptoms: proof of concepts. Early Interv. Psychiatry 2 (2008), 27–33.
38. Nelson, B., Yuen, H.P., Wood, S.J., Lin, A., Spiliotacopoulos, D., Bruxner, A., Broussard, C., Simmons, M., Foley, D.L., Brewer, W.J., Francey, S.M., Amminger, G.P., Thompson, A., McGorry, P.D., Yung, A.R., Long-term follow-up of a group at ultra high risk (“prodromal”) for psychosis: the PACE 400 study. JAMA Psychiatry 70 (2013), 793–802.
39. Orvaschel, H., Puig-Antich, J., Schedule for Affective Disorders and Schizophrenia for School-Age Children-Epidemiologic Version. 1994, Center for Psychological Studies, Nova Southeastern University, Fort Lauderdale, FL.
40. Pelletier, A.L., Mittal, V.A., Negative symptom measurement in individuals at-risk for psychosis. Psychiatry Res. 205 (2013), 181–182.
41. Perkins, D.O., Gu, H., Boteva, K., Lieberman, J.A., Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am. J. Psychiatry 162 (2005), 1785–1804.
42. Pfohl, B., Winokur, G., The evolution of symptoms in institutionalized hebephrenic/catatonic schizophrenics. Br. J. Psychiatry 141 (1982), 567–572.
43. Piskulic, D., Addington, J., Cadenhead, K.S., Cannon, T.D., Ba, Cornblatt, Heinssen, R., Perkins, D.O., Seidman, L.J., Tsuang, M.T., Walker, E.F., Woods, S.W., McGlashan, T.H., Negative symptoms in individuals at clinical high risk of psychosis. Psychiatry Res. 196 (2012), 220–224.
44. Robinson, D.G., Woerner, M.G., Alvir, J.M., Geisler, S., Koreen, A., Sheitman, B., Chakos, M., Mayerhoff, D., Bilder, R., Goldman, R., Lieberman, J.A., Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. Am. J. Psychiatry 156 (1999), 544–549.
45. Ruhrmann, S., Schultze-Lutter, F., Salokangas, R.K., Heinimaa, M., Linszen, D., Dingemans, P., Birchwood, M., Patterson, P., Juckel, G., Heinz, A., Morrison, A., Lewis, S., von Reventlow, H.G., Klosterkotter, J., Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch. Gen. Psychiatry 67 (2010), 241–251.
46. Schultze-Lutter, F., Schimmelmann, B.G., Ruhrmann, S., Michel, C., ’A rose is a rose is a rose’, but at-risk criteria differ. Psychopathology 46 (2013), 75–87.
47. Strassnig, M.T., Raykov, T., O'Gorman, C., Bowie, C.R., Sabbag, S., Durand, D., Patterson, T.L., Pinkham, A., Penn, D.L., Harvey, P.D., Determinants of different aspects of everyday outcome in schizophrenia: the roles of negative symptoms, cognition, and functional capacity. Schizophr. Res. 165 (2015), 76–82.
48. Tan, H.Y., Ang, Y.G., First-episode psychosis in the military: a comparative study of prodromal symptoms. Aust. N. Z. J. Psychiatry 35 (2001), 512–519.
49. Velthorst, E., Nieman, D.H., Becker, H.E., van de Fliert, R., Dingemans, P.M., Klaassen, R., de Haan, L., van Amelsvoort, T., Linszen, D.H., Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis. Schizophr. Res. 109 (2009), 60–65.
50. Winokur, G., Scharfetter, C., Angst, J., Stability of psychotic symptomatology (delusions, hallucinations), affective syndromes, and schizophrenic symptoms (thought disorder, incongruent affect) over episodes in remitting psychoses. Eur. Arch. Psychiatry Neurol. Sci. 234 (1985), 303–307.
51. Yung, A.R., McGorry, P.D., The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr. Bull. 22 (1996), 353–370.
52. Yung, A.R., McGorry, P.D., McFarlane, C.A., Jackson, H.J., Patton, G.C., Rakkar, A., Monitoring and care of young people at incipient risk of psychosis. Schizophr. Bull. 22 (1996), 283–303.
53. Yung, A.R., Phillips, L.J., Yuen, H.P., Francey, S.M., McFarlane, C.A., Hallgren, M., McGorry, P.D., Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group. Schizophrenia Res. 60 (2003), 21–32.
54. Yung, A.R., Yuen, H.P., Berger, G., Francey, S., Hung, T.C., Nelson, B., Phillips, L., McGorry, P., Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk?. Schizophr. Bull. 33 (2007), 673–681.